UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Qualify: a randomized head-to-head study of aripiprazole once-monthly and paliperidone palmitate in the treatment of schizophrenia

Schizophrenia research, 2015-10, Vol.168 (1), p.498-504

2015

Volltextzugriff (PDF)

A Postsynaptic Density Immediate Early Gene-Based Connectome Analysis of Acute NMDAR Blockade and Reversal Effect of Antipsychotic Administration

International journal of molecular sciences, 2023-02, Vol.24 (5), p.4372

2023

Volltextzugriff (PDF)

Correction: Using the Goal Attainment Scale adapted for depression to better understand treatment outcomes in patients with major depressive disorder switching to vortioxetine: a phase 4, single-arm, open-label, multicenter study

BMC psychiatry, 2022-06, Vol.22 (1), p.388-388, Article 388

2022

Volltextzugriff (PDF)

Using the Goal Attainment Scale adapted for depression to better understand treatment outcomes in patients with major depressive disorder switching to vortioxetine: a phase 4, single-arm, open-label, multicenter study

BMC psychiatry, 2021-12, Vol.21 (1), p.622-622, Article 622

2021

Volltextzugriff (PDF)

Correction to: Using the Goal Attainment Scale adapted for depression to better understand treatment outcomes in patients with major depressive disorder switching to vortioxetine: a phase 4, single-arm, open-label, multicenter study

BMC psychiatry, 2022-03, Vol.22 (1), p.170-170, Article 170

2022

Volltextzugriff (PDF)

The Effects of Antipsychotics on the Synaptic Plasticity Gene Homer1a Depend on a Combination of Their Receptor Profile, Dose, Duration of Treatment, and Brain Regions Targeted

International journal of molecular sciences, 2020-08, Vol.21 (15), p.5555

2020

Volltextzugriff (PDF)

Aripiprazole Once-Monthly 400 mg: Comparison of Pharmacokinetics, Tolerability, and Safety of Deltoid Versus Gluteal Administration

The international journal of neuropsychopharmacology, 2017-04, Vol.20 (4), p.295-304

2017

Volltextzugriff (PDF)

Mobile App to Enhance Patient Activation and Patient-Provider Communication in Major Depressive Disorder Management: Collaborative, Randomized Controlled Pilot Study

JMIR formative research, 2022-10, Vol.6 (10), p.e34923-e34923

2022

Volltextzugriff (PDF)

Relationship between response to aripiprazole once-monthly and paliperidone palmitate on work readiness and functioning in schizophrenia: A post-hoc analysis of the QUALIFY study

PloS one, 2017-08, Vol.12 (8), p.e0183475-e0183475

2017

Volltextzugriff (PDF)

Hospitalization rates in patients switched from oral anti-psychotics to aripiprazole once-monthly: final efficacy analysis

Journal of medical economics, 2015-02, Vol.18 (2), p.145-154

2015

Volltextzugriff (PDF)

Adapting the Goal Attainment Approach for Major Depressive Disorder

Neurology and therapy, 2019-12, Vol.8 (2), p.167-176

2019

Volltextzugriff (PDF)

Pharmacoeconomic comparison of aripiprazole once-monthly and paliperidone palmitate from a head-to-head clinical trial in schizophrenia: a US analysis

Drugs in Context, 2016, Vol.5, p.212301-8

2016

Volltextzugriff (PDF)

Reduction in inpatient resource utilization and costs associated with long-acting injectable antipsychotics across different age groups of Medicaid-insured schizophrenia patients

Drugs in Context, 2015-03, Vol.4, p.1-12

2015

Volltextzugriff (PDF)

Inpatient resource use and costs associated with switching from oral antipsychotics to aripiprazole once-monthly for the treatment of schizophrenia

Drugs in Context, 2016-03, Vol.5, p.212273-10

2016

Volltextzugriff (PDF)

The Role of Norepinephrine and Its α-Adrenergic Receptors in the Pathophysiology and Treatment of Major Depressive Disorder and Schizophrenia: A Systematic Review

Frontiers in psychiatry, 2017-03, Vol.8, p.42-42

2017

Volltextzugriff (PDF)

Long-term outcomes of antipsychotic treatment in patients with first-episode schizophrenia: a systematic review

Neuropsychiatric disease and treatment, 2016-01, Vol.12 (Issue 1), p.57-67

2016

Volltextzugriff (PDF)

Aripiprazole once-monthly for treatment of schizophrenia: double-blind, randomised, non-inferiority study

British journal of psychiatry, 2014-08, Vol.205 (2), p.135-144

2014

Volltextzugriff (PDF)

Isolated Sphenoid Sinus Inflammatory Disease-A Report of 14 Cases

Iranian journal of otorhinolaryngology, 2020-03, Vol.32 (109), p.101-107

2020

Volltextzugriff (PDF)

PET clinical study of novel antipsychotic LB-102 demonstrates unexpectedly prolonged dopamine receptor target engagement

Neuropsychopharmacology (New York, N.Y.), 2024-10

2024

Volltextzugriff (PDF)

Aripiprazole once-monthly in the acute treatment of schizophrenia: findings from a 12-week, randomized, double-blind, placebo-controlled study

The journal of clinical psychiatry, 2014-11, Vol.75 (11), p.1254-1260

2014

Volltextzugriff (PDF)

Re-arrangements of gene transcripts at glutamatergic synapses after prolonged treatments with antipsychotics: A putative link with synaptic remodeling

Progress in neuro-psychopharmacology & biological psychiatry, 2017-06, Vol.76, p.29-41

2017

Volltextzugriff (PDF)

An unusual case of complicated rhinosinusitis of the sphenoid sinus involving the cavernous sinus and skull base: Endoscopic sinus surgery and medical therapy

SAGE open medical case reports, 2019, Vol.7, p.2050313X19852885

2019

Volltextzugriff (PDF)

Different effects of the NMDA receptor antagonists ketamine, MK-801, and memantine on postsynaptic density transcripts and their topography: Role of Homer signaling, and implications for novel antipsychotic and pro-cognitive targets in psychosis

Progress in neuro-psychopharmacology & biological psychiatry, 2013-10, Vol.46, p.1-12

2013

Volltextzugriff (PDF)

Effect of brexpiprazole on control of impulsivity in schizophrenia: A randomized functional magnetic resonance imaging study

Psychiatry research. Neuroimaging, 2020-07, Vol.301, p.111085-111085, Article 111085

2020

Volltextzugriff (PDF)

Successful switching of patients with acute schizophrenia from another antipsychotic to brexpiprazole: comparison of clinicians’ choice of cross-titration schedules in a post hoc analysis of a randomized, double-blind, maintenance treatment study

CNS spectrums, 2019-10, Vol.24 (5), p.507-517

2019

Volltextzugriff (PDF)

1 – 25 von 80

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(68)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(60)
Life Sciences & Biomedicine
(57)
Psychiatry
(31)
Schizophrenia
(31)
Male
(27)
Humans
(25)
Adult
(20)
Female
(19)
Neurosciences & Neurology
(19)
Schizophrenia - Drug Therapy
(19)
Antipsychotic Agents - Administration & Dosage
(17)
Clinical Neurology
(16)
Animals
(15)
Middle Aged
(14)
Antipsychotics
(13)
Aripiprazole Once-Monthly
(13)
Aripiprazole
(12)
Long-Acting Injectable
(11)
Pharmacology & Pharmacy
(11)
Psychotropic Drugs
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Qualify: a randomized head-to-head study of aripiprazole once-monthly and paliperidone palmitate in the treatment of schizophrenia

A Postsynaptic Density Immediate Early Gene-Based Connectome Analysis of Acute NMDAR Blockade and Reversal Effect of Antipsychotic Administration

Correction: Using the Goal Attainment Scale adapted for depression to better understand treatment outcomes in patients with major depressive disorder switching to vortioxetine: a phase 4, single-arm, open-label, multicenter study

Using the Goal Attainment Scale adapted for depression to better understand treatment outcomes in patients with major depressive disorder switching to vortioxetine: a phase 4, single-arm, open-label, multicenter study

Correction to: Using the Goal Attainment Scale adapted for depression to better understand treatment outcomes in patients with major depressive disorder switching to vortioxetine: a phase 4, single-arm, open-label, multicenter study

The Effects of Antipsychotics on the Synaptic Plasticity Gene Homer1a Depend on a Combination of Their Receptor Profile, Dose, Duration of Treatment, and Brain Regions Targeted

Aripiprazole Once-Monthly 400 mg: Comparison of Pharmacokinetics, Tolerability, and Safety of Deltoid Versus Gluteal Administration

Mobile App to Enhance Patient Activation and Patient-Provider Communication in Major Depressive Disorder Management: Collaborative, Randomized Controlled Pilot Study

Relationship between response to aripiprazole once-monthly and paliperidone palmitate on work readiness and functioning in schizophrenia: A post-hoc analysis of the QUALIFY study

Hospitalization rates in patients switched from oral anti-psychotics to aripiprazole once-monthly: final efficacy analysis

Adapting the Goal Attainment Approach for Major Depressive Disorder

Pharmacoeconomic comparison of aripiprazole once-monthly and paliperidone palmitate from a head-to-head clinical trial in schizophrenia: a US analysis

Reduction in inpatient resource utilization and costs associated with long-acting injectable antipsychotics across different age groups of Medicaid-insured schizophrenia patients

Inpatient resource use and costs associated with switching from oral antipsychotics to aripiprazole once-monthly for the treatment of schizophrenia

The Role of Norepinephrine and Its α-Adrenergic Receptors in the Pathophysiology and Treatment of Major Depressive Disorder and Schizophrenia: A Systematic Review

Long-term outcomes of antipsychotic treatment in patients with first-episode schizophrenia: a systematic review

Aripiprazole once-monthly for treatment of schizophrenia: double-blind, randomised, non-inferiority study

Isolated Sphenoid Sinus Inflammatory Disease-A Report of 14 Cases

PET clinical study of novel antipsychotic LB-102 demonstrates unexpectedly prolonged dopamine receptor target engagement

Aripiprazole once-monthly in the acute treatment of schizophrenia: findings from a 12-week, randomized, double-blind, placebo-controlled study

Re-arrangements of gene transcripts at glutamatergic synapses after prolonged treatments with antipsychotics: A putative link with synaptic remodeling

An unusual case of complicated rhinosinusitis of the sphenoid sinus involving the cavernous sinus and skull base: Endoscopic sinus surgery and medical therapy

Different effects of the NMDA receptor antagonists ketamine, MK-801, and memantine on postsynaptic density transcripts and their topography: Role of Homer signaling, and implications for novel antipsychotic and pro-cognitive targets in psychosis

Effect of brexpiprazole on control of impulsivity in schizophrenia: A randomized functional magnetic resonance imaging study

Successful switching of patients with acute schizophrenia from another antipsychotic to brexpiprazole: comparison of clinicians’ choice of cross-titration schedules in a post hoc analysis of a randomized, double-blind, maintenance treatment study

Suchergebnisse filtern